Results 181 to 190 of about 22,605 (225)

Design, development, and evaluation of gene therapeutics specific to KSHV-associated diseases. [PDF]

Mol Ther Oncol
Inagaki T, Espera JM, Wang KH, Komaki S, Nair S, Davis RR, Kumar A, Nakajima KI, Izumiya Y.   +8 more
europepmc   +1 more source

Pseudouridine prevalence in Kaposi's sarcoma-associated herpesvirus transcriptome reveals an essential mechanism for viral replication. [PDF]

Proc Natl Acad Sci U S A
Mottram TJ, Harper KL, Vasconcelos EJR, Whitehouse A.   +3 more
europepmc   +1 more source

Integrative functional genomics analysis of Kaposi sarcoma cohorts. [PDF]

Sci Rep
Lacunza E, Fink V, Naipauer J, Salas ME, Gun AM, Goldman MJ, Zhu J, Williams S, Figueroa MI, Cahn P, Coso O, Cesarman E, Ramos JC, Abba MC.   +13 more
europepmc   +1 more source

Characterization of the Kaposi's sarcoma-associated herpesvirus terminase complex component ORF29. [PDF]

Microbiol Spectr
Iwaisako Y, Shimizu K, Suzuki Y, Nakano T, Fujimuro M.   +4 more
europepmc   +1 more source

Correction: Polyamine biosynthesis and eIF5A hypusination are modulated by the DNA tumor virus KSHV and promote KSHV viral infection. [PDF]

PLoS Pathog
Fiches GN, Wu Z, Zhou D, Biswas A, Li TW, Kong W, Jean M, Santoso NG, Zhu J.   +8 more
europepmc   +1 more source

Targeting of Kaposi's sarcoma-associated herpesvirus by immunotoxins directed against the viral G protein-coupled receptor, ORF74.

Biomed Pharmacother
Kildedal DF, Drzazga AK, Sharma A, Berg C, Winther AN, Krogh-Hansen L, Gustavsson M, Kragelund BB, Våbenø J, Lagunoff M, Tsutsumi N, Kledal TN, Jeppesen MG, Rosenkilde MM.   +13 more
europepmc   +1 more source

KSHV: Immune Modulation and Immunotherapy [PDF]

Frontiers in Immunology, 2020
Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is associated with KS, primary effusion lymphoma (PEL), and multicentric Castleman disease (MCD). To ensure its own survival and propagation, KSHV employs an extensive network of viral proteins to subvert the host immune system, resulting in lifelong latent infection.
Grant S Broussard, Blossom A Damania
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

KSHV/HHV8-mediated hematologic diseases

Blood, 2022
Abstract Kaposi sarcoma (KS) herpesvirus (KSHV), also known as human herpesvirus 8, is the causal agent of KS but is also pathogenetically related to several lymphoproliferative disorders, including primary effusion lymphoma (PEL)/extracavitary (EC) PEL, KSHV-associated multicentric Castleman disease (MCD), KSHV+ diffuse large B-cell ...
Ethel Cesarman, Amy Chadburn, Paul G. Rubinstein   +2 more
openaire   +2 more sources

Immunotherapy for KSHV-associated diseases

Current Opinion in Virology, 2022
Kaposi sarcoma herpesvirus (KSHV)-associated diseases (Kaposi sarcoma, multicentric Castleman disease, primary effusion lymphoma, and KSHV inflammatory cytokine syndrome) are associated with immune suppression and dysregulation and loss of KSHV-specific immunity.
Kathryn, Lurain, Robert, Yarchoan, Ramya, Ramaswami   +2 more
openaire   +2 more sources

Kaposi's sarcoma and KSHV

Lancet, The, 1995
Nigel Klein, Richard S Tedder, Silvia Franceschi   +2 more
exaly   +2 more sources